Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP651340.RAKUyq1Cx8ubLEs6SfMx_iypHNPoiqXl4jbNFoKema6h4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP651340.RAKUyq1Cx8ubLEs6SfMx_iypHNPoiqXl4jbNFoKema6h4130_assertion type Assertion NP651340.RAKUyq1Cx8ubLEs6SfMx_iypHNPoiqXl4jbNFoKema6h4130_head.
- NP651340.RAKUyq1Cx8ubLEs6SfMx_iypHNPoiqXl4jbNFoKema6h4130_assertion description "[Concentration response curves to PACAP38, PACAP27, VIP and the VPAC(1) receptor agonist ([Lys15,Arg16,Leu27]-VIP[1-7]-GRF[8-27]) were constructed in the absence or presence of the PAC(1) receptor antagonist PACAP6-38 or the VPAC(1) receptor antagonist, PG97269.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651340.RAKUyq1Cx8ubLEs6SfMx_iypHNPoiqXl4jbNFoKema6h4130_provenance.
- NP651340.RAKUyq1Cx8ubLEs6SfMx_iypHNPoiqXl4jbNFoKema6h4130_assertion evidence source_evidence_literature NP651340.RAKUyq1Cx8ubLEs6SfMx_iypHNPoiqXl4jbNFoKema6h4130_provenance.
- NP651340.RAKUyq1Cx8ubLEs6SfMx_iypHNPoiqXl4jbNFoKema6h4130_assertion SIO_000772 20974589 NP651340.RAKUyq1Cx8ubLEs6SfMx_iypHNPoiqXl4jbNFoKema6h4130_provenance.
- NP651340.RAKUyq1Cx8ubLEs6SfMx_iypHNPoiqXl4jbNFoKema6h4130_assertion wasDerivedFrom befree-20140225 NP651340.RAKUyq1Cx8ubLEs6SfMx_iypHNPoiqXl4jbNFoKema6h4130_provenance.
- NP651340.RAKUyq1Cx8ubLEs6SfMx_iypHNPoiqXl4jbNFoKema6h4130_assertion wasGeneratedBy ECO_0000203 NP651340.RAKUyq1Cx8ubLEs6SfMx_iypHNPoiqXl4jbNFoKema6h4130_provenance.